{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:55:01Z","timestamp":1791244501359,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008253","name":"Shaoxing University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jcms.2026.104535","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T16:49:41Z","timestamp":1774457381000},"page":"104535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neoadjuvant immunochemotherapy does not increase major surgical complications in oral cavity cancer"],"prefix":"10.1016","volume":"54","author":[{"given":"Min","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihong","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcms.2026.104535_bib1","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1002\/cncr.33616","article-title":"Role of induction chemotherapy for oral cavity squamous cell carcinoma","volume":"127","author":"Abdelmeguid","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jcms.2026.104535_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/imt-2023-0174","article-title":"Immunotherapy for head and neck squamous cell carcinoma: current status and perspectives","volume":"16","author":"Daste","year":"2024","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jcms.2026.104535_bib3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/cncr.35198","article-title":"Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?","volume":"130","author":"Gross","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.jcms.2026.104535_bib4","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1245\/s10434-024-16284-8","article-title":"Association of neoadjuvant immunotherapy with postoperative major morbidity after oncologic surgery","volume":"31","author":"Habib","year":"2024","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.jcms.2026.104535_bib5","doi-asserted-by":"crossref","first-page":"E428","DOI":"10.1002\/lary.27902","article-title":"Wound complications in head and neck squamous cell carcinomas after Anti-PD-1 therapy","volume":"129","author":"Hwang","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jcms.2026.104535_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.103018","article-title":"Comparative review of KEYNOTE-689 and NIVOPOSTOP trials and their impact on perioperative immunotherapy in locally advanced head and neck cancer","volume":"140","author":"Imamura","year":"2025","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.jcms.2026.104535_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155489","article-title":"Comprehensive insights into oral squamous cell carcinoma: diagnosis, pathogenesis, and therapeutic advances","volume":"261","author":"Jagadeesan","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.jcms.2026.104535_bib8","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1097\/JS9.0000000000002819","article-title":"Wound healing in cancer patients under immunotherapy","volume":"111","author":"Kuo","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.jcms.2026.104535_bib9","article-title":"Anti-EGFR enhanced neoadjuvant immunotherapy versus neoadjuvant immunochemotherapy for locally advanced oral squamous cell carcinoma","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jcms.2026.104535_bib10","article-title":"Neoadjuvant immunotherapy with or without chemotherapy in locally advanced oral squamous cell carcinoma: randomized, two-arm, phase 2 trial","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jcms.2026.104535_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.otc.2025.08.009","article-title":"Novel treatment approaches in recurrent\/metastatic squamous head and neck cancer","volume":"59","author":"Llop","year":"2026","journal-title":"Otolaryngol. Clin."},{"key":"10.1016\/j.jcms.2026.104535_bib12","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hed.26601","article-title":"Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer","volume":"43","author":"Mays","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.jcms.2026.104535_bib13","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/hed.28182","article-title":"Postdiagnosis smoking cessation and survival outcomes of head and neck cancer patients","volume":"47","author":"Mohebbi","year":"2025","journal-title":"Head Neck"},{"key":"10.1016\/j.jcms.2026.104535_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104742","volume":"212","author":"Pedroso","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jcms.2026.104535_bib15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cncr.35045","article-title":"Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer","volume":"130","author":"Philips","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.jcms.2026.104535_bib16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamaoto.2022.2291","article-title":"Association of neoadjuvant pembrolizumab for oral cavity squamous cell carcinoma with adverse events after surgery in treatment-naive patients","volume":"148","author":"Tang","year":"2022","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jcms.2026.104535_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJMoa2415434","article-title":"Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer","volume":"393","author":"Uppaluri","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcms.2026.104535_bib18","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.2012.43.8820","article-title":"Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma","volume":"31","author":"Zhong","year":"2013","journal-title":"J. Clin. Oncol."}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518226000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518226000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:39:57Z","timestamp":1776127197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518226000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1010518226000922"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2026.104535","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant immunochemotherapy does not increase major surgical complications in oral cavity cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2026.104535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104535"}}